Seeyond Insulet Corp Transaction History

Seeyond

$1.03 Billion
Q4 2022

A detailed history of Seeyond transactions in Insulet Corp stock. As of the latest transaction made, Seeyond holds 1,146 shares of PODD stock, worth $225,441. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,146

Previous 2,416 52.57%

Holding current value

$225,441

Previous $554,000 39.17%

% of portfolio

0.03%

Previous 0.07%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$212.22 - $313.46 $269,519 - $398,094	-1,270 Reduced 52.57%	1,146 $337,000
Q3 2022 Nov 14, 2022	SELL	$224.6 - $281.45 $29,198 - $36,588	-130 Reduced 5.11%	2,416 $554,000
Q2 2022 Aug 12, 2022	SELL	$186.4 - $279.02 $460,408 - $689,179	-2,470 Reduced 49.24%	2,546 $554,000
Q1 2022 May 13, 2022	SELL	$194.8 - $275.7 $29,414 - $41,630	-151 Reduced 2.92%	5,016 $1.34 Million
Q3 2021 Nov 12, 2021	SELL	$260.36 - $307.27 $13,799 - $16,285	-53 Reduced 1.02%	5,167 $1.47 Million

Q2 2021 Aug 13, 2021	BUY	$225.52 - $304.06 $5,412 - $7,297	24 Added 0.46%	5,220 $1.43 Million
Q1 2021 May 14, 2021	BUY	$235.95 - $293.05 $248,691 - $308,874	1,054 Added 25.45%	5,196 $1.36 Million
Q4 2020 Feb 12, 2021	SELL	$215.97 - $265.89 $1.21 Million - $1.49 Million	-5,610 Reduced 57.53%	4,142 $1.06 Million
Q3 2020 Nov 12, 2020	BUY	$192.55 - $236.59 $341,391 - $419,474	1,773 Added 22.22%	9,752 $2.31 Million
Q2 2020 Aug 13, 2020	BUY	$159.17 - $224.73 $583,994 - $824,534	3,669 Added 85.13%	7,979 $1.55 Million
Q1 2020 May 14, 2020	BUY	$130.01 - $216.44 $426,952 - $710,788	3,284 Added 320.08%	4,310 $251,000
Q4 2019 Feb 14, 2020	BUY	$144.81 - $186.0 $148,575 - $190,836	1,026 New	1,026 $176,000

Others Institutions Holding PODD

# of Institutions

613

Shares Held

62.9M

Call Options Held

339K

Put Options Held

916K

View Full List

About INSULET CORP

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $13.7B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

More about PODD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seeyond, based on Form 13F filings with the SEC.

News

Stay updated on Seeyond with notifications on news.

Account